178 related articles for article (PubMed ID: 6280606)
1. Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
Stening G; Gotthammar B; Larsson A; Alenius S; Johansson NG; Oberg B
Antiviral Res; 1981 Nov; 1(4):213-23. PubMed ID: 6280606
[TBL] [Abstract][Full Text] [Related]
2. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy.
Cheng YC; Grill S; Ruth J; Bergstrom DE
Antimicrob Agents Chemother; 1980 Dec; 18(6):957-61. PubMed ID: 6263181
[TBL] [Abstract][Full Text] [Related]
3. Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
Machida H; Sakata S; Kuninaka A; Yoshino H
Antimicrob Agents Chemother; 1981 Jul; 20(1):47-52. PubMed ID: 6269482
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.
Reefschläger J; Pein CD; Cech D
J Med Chem; 1988 Feb; 31(2):393-7. PubMed ID: 2828623
[TBL] [Abstract][Full Text] [Related]
5. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
[TBL] [Abstract][Full Text] [Related]
8. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine.
Larsson A; Alenius S; Johansson NG; Oberg B
Antiviral Res; 1983 Aug; 3(2):77-86. PubMed ID: 6312878
[TBL] [Abstract][Full Text] [Related]
9. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P
Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849
[TBL] [Abstract][Full Text] [Related]
10. Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2.
Suzutani T; Machida H; Sakuma T; Azuma M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1547-51. PubMed ID: 2847634
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine and related analogues: potent and unusually selective antiviral activity of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine against herpes simplex virus type 1.
Bergstrom DE; Ruth JL; Reddy PA; De Clercq E
J Med Chem; 1984 Mar; 27(3):279-84. PubMed ID: 6321735
[TBL] [Abstract][Full Text] [Related]
12. In vitro antiherpesviral activity of 5-alkyl derivatives of 1-beta-D-arabinofuranosyluracil.
Machida H; Sakata S; Kuninaka A; Yoshino H; Nakayama C; Saneyoshi M
Antimicrob Agents Chemother; 1979 Aug; 16(2):158-63. PubMed ID: 485126
[TBL] [Abstract][Full Text] [Related]
13. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
Suzutani T; Machida H; Sakuma T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1046-52. PubMed ID: 2847637
[TBL] [Abstract][Full Text] [Related]
14. Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.
Janz C; Wigand R
Arch Virol; 1982; 73(2):135-43. PubMed ID: 6184033
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
16. Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells.
Ayisi NK; Wall RA; Wanklin RJ; Machida H; De Clercq E; Sacks SL
Mol Pharmacol; 1987 Apr; 31(4):422-9. PubMed ID: 3472064
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Rajcáni J; Reefschläger J
Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D
J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.
Machida H; Sakata S
Antiviral Res; 1984 Jun; 4(3):135-41. PubMed ID: 6089657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
